# Hour 14 PSL Scores: 14:00-14:59

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## PSL Scores at End of Hour 14

| Robot Type | Dim A (Omniscient) | Dim B (Omnipresent) | Dim C (Omnipotent) | PSL | Delta | Band |
|-----------|-------------------|--------------------|--------------------|-----|-------|------|
| Surgical Robots | 7.4 | 5.9 | 7.7 | 7.0 | +0.0 | Advanced |
| Cobots | 7.2 | 6.6 | 6.4 | 6.7 | +0.0 | Advanced |
| RT Positioning | 7.7 | 6.1 | 7.0 | 6.9 | +0.0 | Advanced |
| Needle-Placement | 7.0 | 5.6 | 6.7 | 6.4 | +0.0 | Advanced |
| Social Companion | 5.7 | 7.3 | 4.1 | 5.7 | +0.0 | Intermediate |
| Humanoids | 6.0 | 6.1 | 5.3 | 5.8 | +0.0 | Intermediate |
| RT Motion-Tracking | 8.0 | 6.3 | 7.2 | 7.2 | +0.0 | Advanced |
| Imaging Assistant | 7.2 | 6.9 | 6.0 | 6.7 | +0.0 | Advanced |
| Steerable Needle | 7.4 | 5.3 | 7.1 | 6.6 | +0.1 | Advanced |
| Rehab Exoskeletons | 5.7 | 5.9 | 5.6 | 5.7 | +0.0 | Intermediate |

## Cumulative Site PSL: 65.0 (Advanced Site)

## Scoring Changes This Hour

### Steerable Needle: Dim C (Omnipotent) +0.1 (7.0 to 7.1)

The Steerable Needle robot type receives a Dimension C increase of +0.1 this
hour based on the sustained ablation precision demonstrated during
PAT-ODMND-0111's combined imaging-and-ablation procedure. STEER-01 achieved
needle tip placement accuracy of 1.1 mm from planned target center while
navigating around hepatic vasculature with 3 steering corrections. The
microwave ablation delivered 60 W for 8 minutes, reaching 65 degrees C at
target center and producing a 42 x 38 mm ablation zone with adequate 5 mm
margins around the 32 x 26 mm HCC tumor. This precision in a Stage III HCC
case with IND drug integration (lenvatinib) demonstrates enhanced omnipotent
capability - the robot's ability to execute complex interventional procedures
with high accuracy in a challenging hepatic environment. The PSL increase
from 6.5 to 6.6 reflects this sustained procedural capability validated
across cumulative ablation cases.

Per 21 CFR 312.62, the ablation parameters, needle trajectory data, and
temperature monitoring records were archived with the investigational drug
administration records for the lenvatinib IND protocol.

### All Other Robot Types: No Change

Remaining robot types maintained their scores from the prior hour. While
8 of 10 robot types were exercised this hour, their performance was consistent
with established baselines and did not warrant score adjustments:

- Surgical Robots (7.0): SURG-02 ongoing hepatectomy consistent with
  established surgical precision metrics.
- Cobots (6.7): COBOT-04 biopsy with Grade A samples at established
  force parameters.
- RT Positioning (6.9): RTPOS-02 GBM stereotactic positioning within
  standard accuracy bounds.
- Needle-Placement (6.4): NEEDLE-01 parotid FNA with 0.8 mm accuracy,
  consistent with prior performance.
- Social Companion (5.7): COMPN-03 pediatric anxiety reduction (7/10 to
  3/10), consistent with established interaction metrics.
- Humanoids (5.8): HUMAN-01 gait training with measurable improvement
  (symmetry 0.68 to 0.72), consistent with established rehabilitation
  support capabilities.
- RT Motion-Tracking (7.2): TRACK-02 fraction delivery with 93.8% gating
  efficiency, within established performance range.
- Imaging Assistant (6.7): IMAGE-04 and IMAGE-01 liver assessments at
  standard quality levels.
- Rehab Exoskeletons (5.7): REHAB-01 session initiated, insufficient data
  this hour for score adjustment (session continuing into Hour 15).

## Dimension Analysis

### Dimension A (Omniscient) - Hour 14 Highlights
- RT Motion-Tracking maintains lead at 8.0. TRACK-02 demonstrated real-time
  120 Hz marker tracking with 2.0 ms AI inference latency during
  PAT-ODMND-0107's treatment, confirming sustained data awareness.
- Steerable Needle at 7.4 reflects enhanced awareness from IMAGE-04 data
  integration for ablation planning. Cross-robot data sharing between
  imaging and ablation systems demonstrates growing omniscience per
  ICH E6(R3) Section 4.2.1.
- Surgical Robots at 7.4 with SURG-02 maintaining comprehensive
  intraoperative awareness during ongoing hepatectomy including real-time
  vessel detection and blood loss tracking.

### Dimension B (Omnipresent) - Hour 14 Highlights
- Social Companion leads at 7.3 with COMPN-03 providing 30-minute dedicated
  pediatric session. Digital interaction capabilities maintained for
  multi-patient awareness even during active session.
- Imaging Assistant at 6.9 with 2 of 4 instances active simultaneously
  (IMAGE-04 for HCC mapping, IMAGE-01 for liver metastases), demonstrating
  broad spatial coverage across the imaging wing.
- Steerable Needle at 5.3 reflects inherent single-patient procedural
  commitment during ablation.

### Dimension C (Omnipotent) - Hour 14 Highlights
- Surgical Robots lead at 7.7. SURG-02 demonstrated full range of
  capabilities during hepatectomy including parenchymal transection,
  hemostasis, specimen extraction, and closure.
- RT Motion-Tracking at 7.2 with TRACK-02 delivering precise 2.000 Gy
  (0.0% deviation) across 3 fields.
- Steerable Needle increased to 7.1 based on sustained ablation precision.
  Combined imaging-guided navigation and microwave ablation with IND drug
  integration represents expanding procedural capability envelope.
- Social Companion remains lowest at 4.1 - by design limited to interaction
  and anxiety management rather than clinical procedures.

## USL Comparison Note

The USL framework (Kawchak, 2026; DOI: 10.5281/zenodo.18778220) evaluates
robot technical interoperability. The cross-robot data sharing observed this
hour between IMAGE-04 and STEER-01 (imaging data passed directly to ablation
planning system) exercises the technical interoperability pathways that USL
measures, demonstrating how high USL scores translate into effective clinical
workflows measured by PSL.

| Robot Platform | USL Score | PSL Score (this sim) |
|---------------|-----------|---------------------|
| da Vinci dVRK | 7.1 | 7.0 (Surgical) |
| Franka Panda | 7.4 | 6.7 (Cobot) |
| Boston Dynamics Atlas | 5.8 | 5.8 (Humanoid) |

PSL and USL measure different aspects: USL focuses on technical unification
readiness while PSL focuses on clinical trial performance (omniscience,
omnipresence, omnipotence). The Steerable Needle's Dim C increase this hour
illustrates how sustained clinical performance (PSL) can diverge from
technical readiness (USL) when procedural complexity and precision
consistently exceed baseline expectations.
